| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 1.808 | 7.813 | 12.384 | 4.881 | 9.557 |
| Total Income - EUR | - | - | - | - | - | 1.808 | 13.877 | 12.384 | 4.881 | 9.557 |
| Total Expenses - EUR | - | - | - | - | - | 7.823 | 13.170 | 13.022 | 9.940 | 20.818 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -6.014 | 707 | -638 | -5.059 | -11.261 |
| Net Profit/Loss - EUR | - | - | - | - | - | -6.030 | 471 | -1.009 | -5.059 | -11.261 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ionik Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 22 | 16.630 | 15.696 | 119.819 | 113.603 |
| Current Assets | - | - | - | - | - | 501 | 4.705 | 5.152 | 3.956 | 2.812 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 422 |
| Receivables | - | - | - | - | - | 0 | 3.057 | 920 | 1.180 | 1.498 |
| Cash | - | - | - | - | - | 501 | 1.648 | 4.232 | 2.776 | 892 |
| Shareholders Funds | - | - | - | - | - | -5.989 | -5.021 | -6.519 | -11.558 | -22.755 |
| Social Capital | - | - | - | - | - | 41 | 404 | 406 | 404 | 402 |
| Debts | - | - | - | - | - | 6.513 | 26.416 | 27.367 | 135.333 | 139.170 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Ionik Med S.r.l.